Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2023

Same author

Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis.

Journal of the American College of Cardiology·2023

Same author

Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPF.

Scientific reports·2021

Same author

Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.

British journal of cancer·2021

Same author

Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation.

ESC heart failure·2021

Same author

Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.

Nature communications·2021

Search research articles

Related Experiment Video

Updated: Apr 26, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Republished: Fibrosing organising pneumonia.

Brooke Beardsley¹, Doris Rassl²

¹Department of Anatomical Pathology, Canterbury Health Laboratories, Christchurch, New Zealand.

Postgraduate Medical Journal

|July 19, 2014

Summary

Organising pneumonia, a lung inflammation pattern, involves granulation tissue in airways. While typically responsive to corticosteroids, some patients may develop progressive lung fibrosis.

Keywords:

Inflammation Lung fibrosis

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Apr 26, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Area of Science:

Pulmonary Medicine
Pathology

Background:

Organising pneumonia (OP) is characterized by granulation tissue plugs in small airways and alveoli.
This histological pattern signifies an inflammatory response to lung injury, not a specific disease.
OP can manifest across diverse clinical conditions.

Purpose of the Study:

To describe the histological characteristics of organising pneumonia.
To highlight its non-specific nature as a response to pulmonary injury.
To discuss its typical response to corticosteroid treatment and potential for fibrosis.

Main Methods:

Histological examination of lung tissue.
Review of clinical conditions associated with the organising pneumonia pattern.

Main Results:

Granulation tissue plugs are predominantly found in small airways, alveolar ducts, and peri-bronchiolar alveoli.
The organising pneumonia pattern is observed in various clinical settings.
Most patients respond well to corticosteroid therapy.

Conclusions:

Organising pneumonia is a non-specific histological finding indicating lung injury.
Corticosteroids are generally effective, but progressive fibrosis remains a concern in a subset of patients.